cinacalcet pharmascience international 30 mg tabletti, kalvopäällysteinen
pharmascience international ltd - cinacalcetum hydrochloridum - tabletti, kalvopäällysteinen - 30 mg - sinakalseetti
cinacalcet pharmascience international 60 mg tabletti, kalvopäällysteinen
pharmascience international ltd - cinacalcetum hydrochloridum - tabletti, kalvopäällysteinen - 60 mg - sinakalseetti
cinacalcet pharmascience international 90 mg tabletti, kalvopäällysteinen
pharmascience international ltd - cinacalcetum hydrochloridum - tabletti, kalvopäällysteinen - 90 mg - sinakalseetti
dasatinib accord
accord healthcare s.l.u. - dasatinibin - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastiset aineet - dasatinib accord is indicated for the treatment of adult patients with:• ph+ acute lymphoblastic leukaemia (all) with resistance or intolerance to prior therapy. dasatinib accord is indicated for the treatment of paediatric patients with:• newly diagnosed ph+ all in combination with chemotherapy.
dasatinib accordpharma
accord healthcare s.l.u. - dasatinibin - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastiset aineet - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib. ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib. newly diagnosed ph+ all in combination with chemotherapy.
apomorphine pharmascope 5 mg/ml infuusioneste, liuos, esitäytetty ruisku
pharmascope ltd. - apomorphine hydrochloride - infuusioneste, liuos, esitäytetty ruisku - 5 mg/ml - apomorfiini
losartan pharmascope 12.5 mg tabletti, kalvopäällysteinen
pharmascope ltd. - losartanum kalicum - tabletti, kalvopäällysteinen - 12.5 mg - losartaani
losartan pharmascope 25 mg tabletti, kalvopäällysteinen
pharmascope ltd. - losartanum kalicum - tabletti, kalvopäällysteinen - 25 mg - losartaani
losartan pharmascope 50 mg tabletti, kalvopäällysteinen
pharmascope ltd. - losartanum kalicum - tabletti, kalvopäällysteinen - 50 mg - losartaani
losartan pharmascope 100 mg tabletti, kalvopäällysteinen
pharmascope ltd. - losartanum kalicum - tabletti, kalvopäällysteinen - 100 mg - losartaani